Pediatric Cannabis Single-Substance Exposures Reported to the Michigan Poison Center From 2008–2019 After Medical Marijuana Legalization

Author(s):  
Diana Dean ◽  
Karla D. Passalacqua ◽  
Su Min Oh ◽  
Cynthia Aaron ◽  
Meredith G. Van Harn ◽  
...  
2021 ◽  
Author(s):  
Hayoung Cheon ◽  
Tong Guo ◽  
Puneet Manchanda ◽  
S. Sriram

2019 ◽  
Vol 34 (8) ◽  
pp. 1419-1426 ◽  
Author(s):  
Anuj Shah ◽  
Corey J. Hayes ◽  
Mrinmayee Lakkad ◽  
Bradley C. Martin

2020 ◽  
Vol 50 (4) ◽  
pp. 566-578
Author(s):  
Yen-Han Lee ◽  
Yen-Chang Chang ◽  
Ching-Ti Liu ◽  
Stephan Arndt

This research focuses on associations of medical marijuana legalization with prescription drug misuse, illicit drug use, and a combination of both behaviors. Using three waves of the National Survey of Drug Use and Health (NSDUH, 2016–2018), adult participants (age ≥ 18) were selected for the final study sample ( n = 127,438). Multinomial logistic regression was adjusted for biological, socioeconomic, and substance use measurements. Results from multinomial regression demonstrated that medical marijuana legalization was positively associated with illicit drug use (relative risk ratio [RRR] = 1.33, 95% confidence interval [CI] = [1.17, 1.51]; p < .01) and both prescription drug misuse and illicit drug use (RRR = 1.14, 95% CI = [1.05, 1.25]; p < .01) among U.S. adults. It is recommended to design policy interventions to counter illicit drug use and a combination of both prescription drug misuse and illicit drug use as the result of medical marijuana legalization.


2016 ◽  
Vol 50 (3) ◽  
pp. 373-379 ◽  
Author(s):  
Jonathan M. Davis ◽  
Bruce Mendelson ◽  
Jay J. Berkes ◽  
Katie Suleta ◽  
Karen F. Corsi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document